Fig. 1
From: TP53 protein levels, RNA-based pathway assessment, and race among invasive breast cancer cases
Relative frequency differences (RFDs) and 95% confidence interval (95% CI) for TP53 mutation status as determined by IHC and RNA among black women compared to white women in Luminal A/B clinical and PAM50 subtype cases only
